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Genome-wide association study reveals genetic
variants associated with HIV-1C infection in a
Botswana study population
Andrey K. Shevchenkoa,b, Daria V. Zhernakovaa,c, Sergey V. Malovb,d, Alexey Komissarove, Sofia M. Kolchanovaa,f,1,
Gaik Tamazianb, Alexey Antonikb, Nikolay Cherkasovb, Sergey Kliverg, Anastasiia Turenkoa, Mikhail Rotkevichb,
Igor Evsyukova, David Vlahovh, Prisca K. Thamii,j, Simani Gaseitsiwej,k, Vladimir Novitskyj,l, Myron Essexj,k,
and Stephen J. O’Briena,m,1

Contributed by Stephen J. O’Brien, August 11, 2021 (sent for review April 27, 2021; reviewed by Michael Dean, William Wester, and Jean-Francois Zagury)

Although there have been many studies of gene variant association with different stages of HIV/AIDS progression in United States
and European cohorts, few gene-association studies have assessed
genic determinants in sub-Saharan African populations, which
have the highest density of HIV infections worldwide. We carried
out genome-wide association studies on 766 study participants at
risk for HIV-1 subtype C (HIV-1C) infection in Botswana. Three gene
associations (AP3B1, PTPRA, and NEO1) were shown to have significant association with HIV-1C acquisition. Each gene association
was replicated within Botswana or in the United States–African
American or United States–European American AIDS cohorts or in
both. Each associated gene has a prior reported influence on HIV/
AIDS pathogenesis. Thirteen previously discovered AIDS restriction genes were further replicated in the Botswana cohorts,
extending our confidence in these prior AIDS restriction gene reports. This work presents an early step toward the identification of
genetic variants associated with and affecting HIV acquisition or
AIDS progression in the understudied HIV-1C afflicted Botswana
population.
AIDS

global HIV-1 infections and several times more than any other
HIV-1 subtype. Despite this fact, HIV-1C infection remains
understudied as prior research largely focused on HIV-1 subtypes (mostly B) more prevalent in Europe and in the United
States (2–8).
HIV/AIDS exhibits considerable epidemiological heterogeneity (strength of the innate, humoral, and cell-mediated immune responses, variation in response to antiretroviral therapy,
ART), much of which may be attributed to host genetic factors
Significance
The search for genetic variants associated with resistance or
susceptibility to HIV/AIDS already yielded insights that allowed
developing therapeutics that contribute to dramatic reduction
in AIDS-related comorbidities. Unfortunately, nearly all studies
focused on European-descent populations, even though most
infections happen in Africa. In this genome-wide association
study we explored the genetic background of several hundred
individuals from Botswana in search of associations with HIV
infection. We discovered several genetic variant associations in
genes implicated in HIV/AIDS pathogenesis. We also confirmed
several associations reported in previous research. This study
provides valuable data on the influence of human genetic
variation on HIV-1C infection and pathogenesis in southern
Africa, a region with the world’s largest number of HIV-1 infections.
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H

IV infection is a fatal chronic disease that has spread across
all continents since its emergence in the early 1980s. Important progress has been made against the epidemic in the last
two decades. The global incidence–prevalence ratio has declined
from 11.2% in 2000 to 4.6% in 2018. Despite this, the world is
not yet on track to end HIV/AIDS as a public health threat (1).
There are 38 million (31.6 million to 44.5 million) people in the
world living with HIV; 32.7 million (24.8 million to 42.2 million)
people who died from AIDS-related conditions since the onset
of the pandemic. An estimated 690,000 (500,000 to 970,000) died
of HIV/AIDS in 2019 (1). Despite the important breakthroughs
in therapeutic approaches, as well as efforts and resources
invested in the fight against the HIV epidemic for about four
decades, no efficient vaccine or cure exists.
Sub-Saharan Africa is the region most affected by the HIV
pandemic. Botswana falls within the top three countries with the
highest HIV prevalence in the world, with an HIV prevalence
rate of 20.3% (17.3 to 21.8) among adults (15 to 49 y of age) (1).
Currently HIV-1 subtype C (HIV-1C), which is widespread in
the Botswana population, accounts for more than half of all
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(3–8). African populations in general have the highest overall
genetic variation, and it has been hypothesized that treatmentnaive Botswana people exhibit noticeable heterogeneity in natural disease progression (varying ability to maintain high CD4
counts and low viral load) in part due to the variable host genetic
makeup (2, 9). Complex gene and gene–environment interactions affect HIV-1 infection and AIDS progression in major ways
(6, 10). Much remains to be discovered about the genetic basis of
individual host genetic differences in progression to AIDS in this
geographic region.
Identification of genetic factors is important for several reasons. For example, the mechanism of HIV/AIDS restriction by
genetic variants has previously encouraged the development of
salvage pathway antiretroviral medications (e.g., enfuvirtide,
maraviroc, which block HIV-1 binding to CCR-5 receptors and
membrane fusion), while predicting progression to AIDS for a
given genotype can be used to inform clinical trials for new drugs
(4, 11–14). In this study, we searched for genetic factors associated with HIV-1C infection/acquisition and disease progression
in Botswana.
Genome-wide association studies (GWAS) are a standard
approach to scan for novel genetic variants that are associated
with resistance or susceptibility to a particular disease (15–18).
Here, we employed a GWAS approach to discover gene variants
that regulate HIV-1C acquisition and are also related to HIV-1
pathogenesis. In this GWAS, we identified several novel genetic
variants that demonstrated statistically significant association
with HIV-1C infection in a Botswana cohort using single nucleotide polymorphisms (SNPs) determined by Illumina microarray (MA; n = 809) and by whole-genome sequencing (WGS;
n = 364). We report gene associations for three HIV-1C associated loci: AP3B1, PTPRA, and NEO1. The discoveries were
verified by independent cohort replication and by looking for
previously reported implications in HIV-1 host-pathogenesis.
We further replicated prior AIDS restriction gene (ARG) association signals from analyses with Botswana HIV-1C cohorts,
adding confidence to the existing knowledge about gene influences in HIV/AIDS.
Results
We developed a cohort of 838 young African women living in
Botswana who were exposed to or infected with HIV-1C. Study
participants, each enrolled in one or more Botswana-AIDS
Partnership studies (Table 1), were examined in a GWAS to
search for genetic variants that influenced HIV-1C acquisition.
The cohort was parsed into a case-controlled design with 447
HIV infected individuals and 315 HIV exposed but uninfected
controls (Table 2). We genotyped these samples using two
methods. First, DNA from 476 individuals were genotyped with
the Illumina Human Omni 2.5 M BeadChip array (MA cohort),
which resulted in genotypes for 1,374,256 SNPs after filtering, as
described in Table 1. Second, the complete genomes of 364 individuals (nonoverlapping with the MA study participants) were
sequenced (WGS cohort). SNPs annotated from the WGS
samples were genotyped as described in Methods for a total of
8,636,400 SNPs that passed filters for discordant SNPs, missing
genotypes, failure to conform to Hardy–Weinberg equilibrium
(HWE), and minor allele frequency (MAF) < 0.05 (Table 1).
Genetic-association analysis was carried out with filtered study
participants of three datasets, allowing us to perform both a
discovery and a replication study. Three discovery datasets
(Table 2) were considered: 1) the MA group of 430 females (194
HIV+ and 236 HIV−, but HIV-exposed); 2) the WGS group of
336 females (256 HIV+ and 80 of HIV−, but HIV-exposed); 3)
shared SNPs from the MA and WGS study participants were
then combined and analyzed for 1,333,944 shared SNP variants
determined for a MA-WGS study group of 762 females (447
HIV+ and 315 HIV−, but HIV-exposed).
2 of 9 | PNAS
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We performed a GWAS using logistic regression in PLINK on
the MA, WGS, and combined MA-WGS groups, all exposed to
HIV-1C, looking for genetic variants that influence HIV-1C
acquisition. Manhattan plots for each group were obtained
(Fig. 1 and Table 3). WGS Manhattan plots for HIV infection,
using tests for allele and genotype frequency distribution in
HIV+ vs. HIV− people, revealed significant associations of
multiple SNPs with HIV acquisition (Fig. 1, Table 3, SI Appendix, Table S1, and Dataset S1), including a single SNP,
rs572880838 on chromosome 5 (position 77,590,422; GRCh37)
within the AP3B1 (Adaptor Related Protein Complex 3 Subunit
Beta 1) gene, that reached the standard GWAS threshold for
genome-wide significance after Bonferroni correction (Methods)
for both the allele frequency and dominant genotype models
(P = 7.6 × 10−9; odds ratio [OR] = 6.711) (Figs. 1A and 2A and
Table 3). The AP3B1 gene product, AP-3, is well known to influence HIV-1 gag assembly and AIDS pathogenesis
(Discussion)
Replication and validation of associated variants were performed for the exact implicated SNP association in the nondiscovery cohorts as well as in previously interrogated American
AIDS cohorts that included actively gay male participants, recipients of HIV-1 contaminated clotting factors (hemophiliacs),
contaminated donor blood transfusions, and persons who inject
drugs and who exchanged HIV-contaminated syringes in urban
settings (Table 2). In cases where a discovered associated SNP
was not present in the replication cohort, we tested proxy SNPs
with r2 > 0.8 when feasible. The AP3B1 SNP-rs572880838 had
but one proxy to in the WGS SNP in the Botswana WGS dataset
(rs777424597; r2 > 0.8) (SI Appendix, Fig. S1); however, neither
AP3B1-SNP was included among the genotyped MA SNPs,
making exact SNP replication (or nonreplication) impossible.
A less stringent but informative “gene region” replication
approach involved the loading of the GWAS results (WGS and
MA) for discovery and replication cohorts into the GWATCH
program (9, 18). GWATCH includes a suite of GWAS analytical
programs that allow discovered SNP association signals to be
quantified, viewed, and compared for gene region associations
with multiple AIDS association test hypotheses and statistical
models (i.e., HIV infection, Cox regression for survival analysis,
case-control categorical analyses of AIDS progression, various
AIDS defining pathologies, and progression to AIDS after ART
treatment) (Methods). We used GWATCH to explore and replicate AIDS associations in AIDS progression tests in the replication African American (AA) cohort-ALIVE (n = 1,460 study
participants genotyped with 700,022 SNPs) (Fig. 2B and Table 2)
(https://botswana.gen-watch.org/). In addition, the AP3B1 gene
showed a series of SNPs that were highly associated with AIDS
progression (P = 1.7 × 10−5 for Cox regression for survival
analysis), including various AIDS defining end point analyses of
the United States-European American (EA) cohort (n = 1,527
study participants genotyped with 700,022 SNPs; P = 2.1 × 10−3)
(Table 2 and SI Appendix, Fig. S2) (https://botswana.gen-watch.
org/).
The associated SNP (rs572880838) is located in the promoter
(regulatory 5′UTR region) of the AP3B1 gene, which comprises
27 exons encoding a 140-kD, 194-amino acid protein AP3B1.
This promoter region is a binding site for multiple different
transcription factors (19); rs572880838 could potentially influence the regulation of AP3B1 gene transcription or affect the
secondary structure of the transcript itself (SI Appendix, Fig. S3).
The rs572880838 has a noticeably high MAF (MAF = 0.379) in
the Botswana population (based on our dataset of 336 WGS),
where HIV-1C infection is prevalent. This Botswana MAF is
higher than in any of the human populations studied to date. In
the 1000 Genomes Project the highest detected population MAF
of an AP3B1 SNP (rs572880838) is 0.2654 (Gambian) (20). Two
(rs572880838) SNP alleles are distributed in TT and TG
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Table 1. Botswana study participants and SNP filtering

Study participant filtering steps
WGS

MA

MA-WGS (combined- shared SNPs)

Annotated SNPs and filtering steps
WGS

MA

MA-WGS (combined-shared SNPs)

Step
Total subjects
Discordant genotypes (WGS/MA)
No phenotype
low genotyping rate
IBD
PCA outliers
Males
Total used
Total subjects
MA/WGS duplicates
PCA outliers
Males
Total used
Total subjects
MA/WGS duplicates
Discordant genotypes (WGS/MA)
No phenotype
low genotyping rate
IBD
PCA outliers
Males
Total used
Loaded from .bim file
Discordant SNPs (>5%)
Missing genotype data (0.05)
HWE
Minor allele threshold (0.05)
Total used
Loaded from .bim file
Discordant SNPs (>5%)
Missing genotype data (0.05)
HWE
Minor allele threshold (0.05)
Total used
Loaded from .bim file
Missing genotype data (0.05)
HWE
Minor allele threshold (0.05)
Total used

Dropped

3
1
2
2
0
20

333
6
40

335
1
1
1
2
10
61

66,218
869,548
164,425
9,978,835

66,218
8,250
134
373,743

5,981
2,066
363,591

Included
364
361
360
358
356
356
336
336
809
476
470
430
430
1,173
838
837
836
835
833
823
762
762
19,715,426
19,649,208
18,779,660
18,615,235
8,636,400
8,636,400
1,822,601
1,756,383
1,748,133
1,747,999
1,374,256
1,374,256
1,705,582
1,699,601
1,697,535
1,333,944
1,333,944
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In the top half are steps for filtering of study participants as described in Methods. Each row includes the
number of individuals dropped (filtered) and retained in each step. Total indicates the final count of individuals
with genotypes actually used in the analyses of MA, WGS, and combined MA-WGS cohorts from Botswana. In the
bottom half are the same for filtering steps for SNPs. IBD, identity by descent test for close relative; PCS, principal
component analysis; HWE, Hardy–Weinberg departue at P > 0.0001.

genotypes in the Botswana population, while the expected homozygous GG genotype is remarkably absent. The same AP3B1
SNP (rs572880838) GG genotype is also completely absent
among all (African, European, and Asian) populations sequenced in the 1000 Genomes Project (n = 2,504 people), potentially indicating an adverse (perhaps lethal) phenotype for the
AP3B1 SNP (rs572880838) GG genotypes worldwide. Several
mutations, including a 63-bp deletion of AP3B1 Exon 15, can
cause Hermansky–Pudlak syndrome, a rare inherited disorder
characterized by decreased pigmentation (albinism), visual impairment, and blood platelet dysfunction that is sometimes fatal
(21–24). To date there are no clinical pathologies reported in
association with the SNP rs572880838 in the AP3B1 gene, here
associated with HIV-1C acquisition in Botswana.
A second gene-association signal that approached (but did not
exceed) genome-wide significance for the WGS dataset involves

SNPs within the PTPRA (protein tyrosine phosphatase receptor
type A) locus on chromosome 20 (rs6076463; P = 8.3 × 10−7;
OR = 0.172 for allele and dominant genotype models) (Figs. 1A
and 3A, Table 3, SI Appendix, Table S1, and Dataset S1). This
SNP has multiple proxy SNPs that are all associated with HIV
acquisition (Fig. 3A). The strongest PTPRA SNP (rs6076463; P =
8.3 × 10−7; OR = 0.172) was not genotyped in the MA cohort nor
was any informative linkage disequilibrium (LD) proxy SNP included in the MA genotyped SNPs. The PTPRA gene region
showed multiple SNP associations with progression to AIDS
endpoints revealed in the GWATCH snapshot of AAs (Fig. 3B)
(P = 8.3 × 10−4; https://botswana.gen-watch.org/). PTPRA gene
variants were also significantly associated with the development
of certain AIDS defining conditions (sequelae; namely Kaposi’s
sarcoma, PJP [Pneumocytis jiroveci pneumonia], B cell lymphoma) in the EA cohorts screened by GWATCH (Fig. 3C) (P =

Shevchenko et al.
Genome-wide association study reveals genetic variants associated with HIV-1C infection in
a Botswana study population

PNAS | 3 of 9
https://doi.org/10.1073/pnas.2107830118

MEDICAL SCIENCES

Cohort

Table 2. Cohorts interrogated in this study
Application

Cohort

Genotyping
platform

Discovery
Discovery
Combined
cohort
Replication

Botswana
Botswana
Botswana

WGS
MA
MA+WGS

336
430
762

United
States-EA
United
States-AA

MA

1,527

MA

1,460

Replication

n
individuals HIV+ HIV−

Phenotype

SNPs after filtering (see
Table 1)

Source (if
published)

HIV acquisition
HIV acquisition
HIV acquisition

8,636,400
1,374,256
1,333,944

Present study
Present study
Present study

HIV acquisition; AIDS progression;
sequelae; ART
HIV acquisition; AIDS progression;
sequelae; ART

700,022

(8, 18)

700,022

(8, 18)

256 80
194 236
447 315

AA, African Americans; EA, European Americans.
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3.2 × 10−4). The PTPRA gene has also been reported as having a
role in HIV/AIDS pathogenesis (25–27) (Discussion)
A third genetic association, initially detected as genome-wide
significant in the GWAS on MA (Fig. 1B), involves multiple
SNPs within the promoter region of the NEO1 gene associated
with HIV infection (chromosome band 15q24.1; rs9920504; P =
1.03 × 10−5; OR = 0.465) (Fig. 4A, Table 3, SI Appendix, Table
S1, and Dataset S1). A GWATCH screen shot showed multiple
SNPs within the NEO1 gene in the AA cohort that were associated with AIDS progression using Cox regression for survival
analysis (P = 7.94 × 10−5) (Fig. 4B). Furthermore, NEO1 gene
variants were also associated with the development of specific
AIDS-defining conditions (sequelae: Kaposi’s sarcoma, PCP,
B cell lymphoma) in the EA cohorts screened by GWATCH (SI
Appendix, Fig. S4) (P = 9.59 × 10−5). Finally, the identical NEO1
SNP of the discovery cohort analysis (rs9920504) (Fig. 4A and
Table 3) was also significantly associated in an HIV infection
GWAS using the MA-WGS Botswana combined cohort (P =
1.09 × 10−5) (Fig. 4C). The NEO1 gene encodes a cell surface
protein member of the immunoglobulin superfamily that functions in multiple tissues and in chronic inflammation of HIV
infected patients (28–30) (Discussion). The combined MA-WGS

cohort analyses for allele and genotyping effect did not yield any
SNPs that exceeded genome-wide significance in allele or genotype association tests (https://botswana.gen-watch.org/).
We further searched across the three Botswana discovery cohorts (Table 2) for possible SNP and gene replications in HIV-1
acquisition of previously reported ARGs. We found 13 genes of
the 41 tested that showed P < 0.005 for one or more stages of
HIV infection and AIDS pathogenesis (Table 4 and SI Appendix,
Table S2) (4, 7, 8). These include several loci within the HLA
gene complex, as seen previously in EA-based GWAS but not
reported to date in African cohorts. The CCR2-64I allele was
associated with HIV infection in a Kenya cohort of sex workers
(41), while PROX1 has not been replicated to our knowledge
prior to this study (32). The failure to replicate some of the
additional associated ARGs might be explained in some cases by
differences in ethnic populations used for GWAS and in HIV
subtypes. For example, CCR5-Δ32 is not present among African
ethnic groups. Despite these differences, we were able to replicate the loci in such genes as NCOR2, TRIM5, CXCL12, and
several HLA genes (Table 4). The present replication increases
our confidence in the validity of these prior genetic associations.

Fig. 1. Manhattan plots for associations with HIV infection using tests for allele and genotype frequency distribution in HIV+ vs. HIV− people. (A) WGS
dataset of 336 people under the allelic model revealed departure of 8,636,400 SNPs from expectation, including associations within the AP3B1 (rs572880838;
position 5:77,590,422; P = 7.6 × 10−9; OR = 6.711) and PTPRA (rs6076463; position 20:3012815; P = 8.33E-07; OR = 0.172) genes. (B) MA dataset: 430 people
(1,374,256 SNP) under the allelic model revealed 1,374,256 SNPs. NEO1 (rs9920504; position 15:73284181; P = 1.03 × 10−5; OR = 0.465) (Table 3). Manhattan
plots for the combined MA-WGS cohort (n = 762) did not reveal any SNPs that exceeded genome-wide significance (P < 3.75 × 10−8).
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Table 3. Gene variants associated with HIV-1C infection
Cohort
WGS

MA

CHR

SNP

Coordinates

Allele (minor)

Test

NMISS

OR

STAT

P value

Gene

Distance

RR

AR

EF

5
5
20
20
20
20
15
15
15
15

rs572880838
rs572880838
rs6076463
rs6076463
rs3787480
rs3787480
rs9920504
rs7172316
rs9920504
rs7172316

77590422
77590422
3012815
3012815
3016895
3016895
73284181
73287152
73284181
73287152

G
G
T
T
A
A
C
G
C
G

ALLELIC
DOM
ALLELIC
DOM
ALLELIC
DOM
ALLELIC
ALLELIC
DOM
DOM

333
333
336
336
336
336
422
430
422
430

6.711
6.711
0.172
0.172
0.179
0.179
0.465
0.470
0.437
0.445

5.78
5.78
−4.93
−4.93
−4.59
−4.59
−4.41
−4.39
−4.06
−4.01

7.62E-09
7.62E-09
8.33E-07
8.33E-07
4.46E-06
4.46E-06
1.03E-05
1.14E-05
4.94E-05
6.05E-05

AP3B1
AP3B1
PTPRA
PTPRA
PTPRA
PTPRA
NEO1
NEO1
NEO1
NEO1

0
0
0
0
0
0
59870
56899
59870
56899

1.210
NaN
0.564
NaN
0.573
NaN
0.648
0.654
0.398
0.395

0.074
NaN
−0.029
NaN
−0.025
NaN
−0.102
−0.100
−0.040
−0.039

0.029
NaN
0.030
NaN
0.025
NaN
0.018
0.017
0.015
0.015
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Discussion
In this study we performed a GWAS analysis using a combination of WGS and MA data obtained from 766 individuals (after
filtering) (Table 1) from Botswana, either infected or exposed to
HIV-1C, in order to identify genetic factors associated with HIV1C acquisition in a Botswana population. The results presented
reveal candidate gene associations with HIV-1C acquisition and
were replicated in independent AIDS cohorts (Table 2). This is
one of the few studies of the impact of human genetic variation
on HIV-1C infection and pathogenesis in Botswana or in
southern Africa, a locale with the world’s majority of HIV-1
infections. We report here several genes with significant association with HIV-1C acquisition: AP3B1, PTPRA, and NEO1
(Table 3). Evidence of replication in independent datasets
(listed in Table 2) including AA AIDS cohorts is presented for
each associated locus (Results). We researched the recently
discovered loci associated with HIV-1C infection and found
that each gene plays an important functional role in HIV/AIDS
disease processes.

AP3B1 encodes a clathrin-associated protein complex required for HIV-1 assembly and release (42–44). The matrix region of HIV-1 Gag interacts directly with the δ-subunit of the
AP-3 complex (coded by the AP3B1 gene), and this interaction
plays an important functional role in viral particle assembly.
Disruption of this interaction eliminates Gag trafficking to
multivesicular bodies and diminishes HIV particle formation
(43). In cultures of AP-3–deficient fibroblasts, induced by mutations in the AP3B1 gene, HIV-1 particle assembly and release
are diminished, while both transient and stable expression of the
full-length wild-type β3A subunit in these cells restores the impaired virus assembly and release (44). Intact and stable AP-3
complex is required for HIV-1 assembly and release, and the
involvement of the AP-3 complex in late stages of the HIV-1
replication cycle is independent of clathrin-mediated endocytosis
(44). The β-subunit of AP-3 is a target of IP7-mediated pyrophosphorylation, which modulates its interaction with Kif3A (a
motor protein of the kinesin superfamily, which is also involved
in an intracellular process required for HIV-1 Gag release) and,

Fig. 2. GWATCH snapshots of associations in the AP3B1 gene region for HIV infection and AIDS progression. GWATCH is a web-based dynamic real-time
genome browser designed to discover, view, and assess hits from GWAS and WGS association studies (https://botswana.gen-watch.org/) (9, 18). The platform
displays a three-dimensional viewer above and moving along human chromosomes with baseline x axis listing all association tests performed in the GWAS.
Adjacent SNPs genotyped along each chromosome are the indices of the y axis. The rising blocks illustrate the resulting log of P value obtained (blocks are
shown only for P < 10−3 to avoid clutter of noise) for each SNP–test combination, with color showing direction of association (red for susceptible vs. green for
protective) and color intensity indicating the hazard ratio/OR (unified under the term QAS for Quantitative Association Statistic) (18) of each association. The
combination of nonindependent proxy SNPs (which track the operative SNP by LD) and the nonindependent SNP association tests produce clusters of P value
peaks in associated regions. Nonassociated regions are generally flat with random false signals appearing infrequently. (A) HIV infection tests in the Botswana
WGS discovery dataset (n = 336 study participants [256 HIV+ and 80 HIV−] genotyped with 8,636,400 SNPs). (B) AIDS progression tests in the replication AA
cohort (n = 1,460 study participants genotyped with 700,022 SNPs) (Table 2). The American replication cohorts consist of multiple tests with different numbers
of individuals in each. The individuals’ numbers for each test are listed in GWATCH (https://gen-watch.org/#/option0) under the “List of tests & Manhattan
plots” tab for each cohort. The elevated P values reflect a series of different case-control hypothesis tests for AIDS progression among HIV infected AA study
participants (https://botswana.gen-watch.org/) (9, 18).
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AR, attributable risk; EF, explained fraction; Distance, distance to the closest gene (see column Gene); NaN, not a valid number; NMISS, number of
nonmissing individuals included; RR, relative risk; STAT, coefficient t-statistic.
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Fig. 3. GWATCH snapshots of associations in the PTPRA gene region. (A) HIV infection tests in the Botswana WGS discovery cohort (n = 336 study participants
[256 HIV+ and 80 HIV−] genotyped with 8,636,400 SNPs). (B) AIDS progression tests in the replication AA cohort (also called ALIVE cohort, n = 1,460 study
participants genotyped with 700,022 SNPs). (C) HIV/AIDS progression (sequelae) tests in the Botswana replication EA Mod A cohort (n = 1,527 study participants genotyped with 700,022 SNPs) (https://botswana.gen-watch.org/) (9, 18).

as a consequence, affects the release of HIV-1 virus-like
particles (42).
PTPRA encodes a membrane receptor, member of the protein
tyrosine phosphatase (PTP) family, which regulates a variety of
cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. The PTPRA gene
was shown to be up-regulated in CD4+ cells from HIV-1 patients (25, 26). It has also been detected among exosomal
proteins found in urinary extracellular vesicles from HIV-1+
patients (27).
The human Neogenin 1 (NEO1) gene encodes a multifunctional cell surface protein that is a member of the immunoglobulin superfamily, implicated in tissue morphogenesis,
angiogenesis, myoblast differentiation, and axon guidance (28).
Plasma membrane expression of NEO1 is down-regulated in
CEMT4 T cells infected with VSV-G pseudotyped HIV-1 (29).
Neogenin also demonstrates a greater than twofold increased
relative abundance in HIV-1+ blood plasma and some studies
suggest that it may play an important role in chronic inflammation induced by HIV infection. It was proposed that functional
regulation of neogenin plasma level may have a therapeutic
value in HIV+ patients (30).
It seems notable that all three important associations discovered in the African Botswana population showed gene replications in the United States-AA AIDS cohort (Figs. 2B, 3B, and 4B
and Table 2). By contrast, over 30 ARGs were discovered in the
United States Caucasian cohort (4, 7, 8) with very few previously
described ARGs found in the same United States-AA cohort
(Table 2). This difference may actually be attributable to ethnic
genetic background. Furthermore, we were able to replicate the
reported associations for 13 previously found ARGs, such as
6 of 9 | PNAS
https://doi.org/10.1073/pnas.2107830118

NCOR2, TRIM5, CXCL12, and several HLA genes (Table 4 and
SI Appendix, Table S2). These replications provide additional
evidence in support of the previously reported associations and
strengthen our confidence in the newly detected ones.
Our study was limited by rather small sample sizes and a
gender emphasis on females, though previous ARG studies in
AIDS cohorts from Western countries were biased toward male
participants. More expansive studies in the future are certainly
needed in this population, as well as in others, particularly in
other African regions, ethnic groups, in men and in children in
order to assess the findings more thoroughly. Multiple kinds of
genome-level data (e.g., genomic DNA, epigenetic data, transcriptome data, siRNA screens) used in conjunction with resequencing strategies identifying rare causal variants are necessary
to improve our comprehension of the role of host genome variability on HIV-1 acquisition, progression, and transmission at
regional and global scales (6, 17). Finally, nongenetic factors are
unaccounted for in present-day GWAS studies, such as host
microbiome, epigenome, environmental, and social factors,
which surely contribute to HIV-1 transmission and progression.
These components should be assessed by the future study designs
in this important search for the host genetic determinants of
HIV/AIDS transmission and pathogenesis (6).
Methods
Populations Studied. Participants from two earlier Botswana Harvard AIDS
Institute Partnership studies, Mashi and Tshedimoso, were enrolled in
GWAS study. The Mashi study (clinicaltrials.gov identifier NCT00197587;
NIH R01 HD37793) was a mother-to-child prevention 2 × 2 factorial
randomized clinical trial with peripartum (single-dose nevirapine vs.
placebo) and postpartum infant feeding formula vs. breastfeeding with
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Fig. 4. GWATCH snapshots of associations in the NEO1 gene region. (A) HIV infection tests in the discovery MA cohort (n = 430 study participants genotyped
[194 HIV+ and 236 HIV−] with 1,374,256 SNPs). (B) AIDS progression tests in the replication United States-AA cohort (n = 1,460 study participants genotyped
with 700,022 SNPs). (C) HIV infection tests in the replication combined MA-WGS cohort (n = 762 study participants genotyped with 1,333,944 SNPs) (https://
botswana.gen-watch.org/) (9, 18).

infant zidovudine prophylaxis) interventions presented elsewhere
(45–49). A subset of 436 individuals who participated in Mashi study
were enrolled in this study. The Tshedimoso study (NIH AI057027
Markers of Viral Set Point in Primary HIV-1C Infection) was presented
elsewhere (50–70).
A subset of 373 individuals who were screened for the Tshedimoso study
were enrolled in the GWAS study. The samples all came from the two cohorts

that were collected/enrolled for the original clinical studies of largely Tswana
ethnicity study participants.
The largest cohort was recruited only for HIV+ pregnant women to test
interventions to prevent mother-to-child transmission. Thus, no males were
ever involved in that cohort. As this study was performed in Botswana, a
country with one of the highest HIV-1 prevalence (20.3%), a high proportion
of citizens could be considered as likely exposed to HIV-1 infection.

Table 4. Replications of previously discovered AIDS restriction genes in the cohorts of this study
Dataset
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WGS

MA

Gene

Chr

SNP

Position

test

P value

Odds ratio

Citation (original source)

NCOR2
PROX1
PROX1-AS1
TRIM5
CXCL12 (SDF1)
HCP5
MYH9
HLA-DRB1
TSG101
HLA-DMB
HLA-C
HLA-A
CCR2*
TRIM5
CXCL12 (SDF1)
NCOR2
HLA-DQB1-AS1

12
1
1
11
10
6
22
6
11
6
6
6
3
11
10
12
6

rs701025
rs366684
rs853757
rs71490145
rs1898318
rs7746061
rs28478212
rs9270209
rs867590536
6:32908833
rs1049709
rs1059514
rs62242985
rs73404271
rs800323
rs12814949
rs6689

125042336
214187262
214051639
5691528
44825430
31419216
36734593
32556443
18508258
32908833
31236854
29911190
46385638
5739483
44801673
124976612
32627700

DOM
DOM
REC
DOM
DOM
ALLELIC
ALLELIC
ALLELIC
ALLELIC
ALLELIC
DOM
REC
ALLELIC
ALLELIC
REC
DOM
ALLELIC

8.0E-05
5.1E-04
5.6E-04
5.9E-04
6.6E-04
1.2E-03
2.1E-03
2.5E-03
2.8E-03
3.4E-03
5.5E-03
5.8E-03
8.3E-03
4.2E-04
1.8E-03
5.3E-03
8.7E-03

3.48
0.33
0.24
0.38
0.33
0.31
0.38
2.19
0.39
0.36
0.37
0.34
1.79
2.17
0.39
0.47
0.54

(31)
(32)
(32)
(33)
(34)
(35)
(36)
(37)
(38)
(39)
(35)
(40)
(41)
(33)
(34)
(31)
(37)

See SI Appendix, Table S2 for more information on the original associations.
*In LD; 9,587 bp.
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Individual exposure was not quantified. The data were obtained in collaboration with Harvard T. H. Chan School of Public Health AIDS Initiative
(Boston, MA) and the Botswana/Harvard AIDS Institute (Gaborone,
Botswana).
This study was conducted by the Botswana Harvard AIDS Institute Partnership and approved according to The Declaration of Helsinki. All participants consented to participate in the study. Institutional Review Board (IRB)
approval was from Botswana Ministry of Health and Wellness–Health Research Development Committee and Harvard School of Public Health IRB
(reference no.: HPDME 13/18/1).
Whole-Genome Sequencing. WGS was performed for 364 samples at 30×
coverage (Table 1). Quality control of raw WGS reads was performed using
FastQC v0.11.5 (71) and 23-mer counts distribution with KraTER (72). Trimmomatic (73) with default parameters was used to remove adapters and
trim low-quality read ends. Trimmed reads were mapped to the human
reference genome GRCh38 (top-level main chromosomes) using BWA-MEM
v0.7.15 (74) with default parameters and the read alignments were sorted
with SAMtools sort v0.1.19 (75, 76). These alignments were then used for
genotyping by SAMtools and BCFtools toolchain (SAMtools mpileup with -Q
30 -q 30 -m, and BCFtools call) (76). After checking the F1-score between
genotypes in WGS and microarray data with the DP (the variant read depth)
range from 1 to 10 and for QUAL (the Phred-scaled quality score of alternative alleles of a variable site) from the set 15, 20, 25, 30, 35, and 40 variants with DP < 5 and QUAL < 20, and singletons with single called genotype
were filtered out. The resulting variants were annotated using Ensembl (19).
VEP WGS genotypes were lifted down to genome build hg19 using UCSC
liftOver tool to make them compatible with MA data.
WGS Sample Filtering. All genotype quality control was performed using
PLINK 1.9 (77) and custom scripts. First, for the samples with both Illumina
MA genotypes and WGS genotypes, we calculated the fraction of concordant genotypes between the two methods. WGS samples with genotype
concordance below 90% were removed. All males were removed, as there
were no HIV-infected samples among them. In addition, we removed principal component analysis (PCA) outliers based on visual inspection of the plot
of PC1 and PC2, samples with missing genotype rate >5% and cryptic relatives (PI_HAT > 0.25) (Table 1 and SI Appendix, Fig. S5A). These steps resulted
in 336 study participants independent of the microarray individuals (Tables 1
and 2).
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MA Sample Filtering. For MA sample filtering, 809 individual samples were
genotyped using the Illumina Infinium Omni2.5-8 BeadChip genotyping MA
[333 samples which overlap with WGS were excluded from the MA dataset
(Table 1)]. All males were removed, as were PCA outliers, samples with
missing genotype rate > 1%, and cryptic relatives (PI_HAT > 0.01) based on
PLINK 1.9 variant statistics (Table 1). Sample filtering resulted in 430 individuals genotyped by microarray that were independent of the WGS cohort
(Tables 1 and 2 and SI Appendix, Fig. S5B). Recently, additional MA chips
have been developed for specifically evaluating African populations, namely
the Infinium H3Africa Consortium Array (v2) and African Diaspora Power
Chip, but these were unavailable at the time of our genotyping.

the association tests. Association tests were performed using PLINK v1.9
logistic regression: we applied additive allelic (–logistic) models for alleles,
dominant (–logistic dominant), recessive (–logistic recessive), and codominant (–logistic genotypic) models for genotypes. PCs 1 and 2 were used as
covariates (–covar) in the WGS dataset, and PC1 was used as a covariate in
the MA dataset to account for potential batch effects based on visual inspection of PCA plots. To avoid inadequate P values in the codominant
model, we calculated the P value only for the variants having enough observations (≥3) for each sample group, thus excluding those variants for
which it is not possible to test the codominant model.
The GWAS P value threshold for genome-wide significance for WGS and
MA-based GWAS follows the corrected P value threshold convention (P < 5 ×
10−8 and P < 10−5, respectively) (78). These thresholds are corrected from the
standard Bonferroni application that assumes every genetic variant tested is
independent of the others (i.e., ignoring LD) and considering false-discovery
rate procedures, permutation-based approaches, and Bayesian approaches
(78). Relative risk, attributable risk, and explained fraction were calculated
as defined in refs. 8 and 79.
The numbers of HIV+ and HIV− study participants used for each test for
Botswana analyses are presented in Table 2 and also in Figs. 2–4. The
American replication cohorts consist of multiple tests with different numbers
of individuals in each. The individuals’ numbers for each test are listed in
GWATCH (https://gen-watch.org/#/option0) under the “List of tests & Manhattan plots” tab for each cohort.
Visualization of the Results Using GWATCH. Genotyping and clinical data were
loaded into the GWATCH analytical suite (9, 18) for further analysis and
visualization. GWATCH is a web-based dynamic real-time genome browser
designed to discover, view, and assess genetic association hits and genomic
environment using multiple association test designs from GWASs (botswana.
gen-watch.org/). GWATCH displays a moving three-dimensional viewer
above along human chromosomes with baseline x axis listing all association
tests performed in the GWAS (https://www.youtube.com/watch?
v=vFHRCb4bUGs). Adjacent SNPs genotyped along each chromosome are
the indices of the y axis. The rising blocks (Figs. 2–4) illustrate the resulting
negative logarithm with base 10 of P values obtained for each SNP–test
combination, with color showing the direction of association (green indicates allele or genotype resistance to infection or disease OR < 1.0; red indicates susceptibility OR > 1.0). Color intensity of the value bars indicate the
hazard ratio/OR of each association listed in Table 3. The P values for the
gene-associated SNPS in replication cohorts were corrected by the number
of SNPS in each gene interrogated in SI Appendix, Table S3.
Data Availability. SNP genotype data have been deposited in https://botswana.gen-watch.org/ (Botswana GWATCH database database). All other
study data are included in the article and supporting information. Previously
published data were used for this work (18).

Association Tests. Prior to testing genetic variants for association with HIV, we
performed SNP filtering and excluded SNPs with call rate < 95%, MAF < 5%
or HWE P value < 1e-4 (Table 1). The resulting genotype data were used for
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